Related Experiment Video
Updated: Feb 18, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
CROI 2017: Complications and Comorbidities of HIV Disease and Its Treatment
Judith S Currier1, Diane V Havlir2
1University of California Los Angeles, Los Angeles, CA, USA.
Insights
HIV complications, including chronic diseases and infections, were a key focus at the 2017 Conference on Retroviruses and Opportunistic Infections (CROI). Research highlighted progress in predicting and managing these serious comorbidities.
Area of Science:
- Infectious Diseases
- Internal Medicine
- Public Health
Background:
- Complications of Human Immunodeficiency Virus (HIV) disease remain a significant clinical challenge.
- The 2017 Conference on Retroviruses and Opportunistic Infections (CROI) addressed critical aspects of HIV management.
Purpose of the Study:
- To summarize research presented at CROI 2017 concerning HIV-related complications.
- To highlight advancements in understanding and managing noncommunicable chronic diseases and opportunistic infections in individuals with HIV.
Main Methods:
- Review of studies presented at the 2017 Conference on Retroviruses and Opportunistic Infections (CROI).
- Focus on research identifying predictors and interventions for HIV comorbidities.
Main Results:
- Studies examined noncommunicable chronic diseases such as cardiovascular disease, obesity, bone disease, and malignancies.
- Research also covered opportunistic infections including Mycobacterium tuberculosis and cryptococcosis.
- Progress was made in identifying predictors and interventions for these complications.
Conclusions:
- Continued focus on managing diverse complications is crucial for individuals living with HIV.
- Advancements in understanding predictors and treatments can improve patient outcomes.
Abstract:
Complications of HIV disease remained a major focus at the 2017 Conference on Retroviruses and Opportunistic Infections (CROI), and included studies focused on noncommunicable chronic diseases (eg, cardiovascular disease, obesity, bone disease, and malignancies) and opportunistic infections (Mycobacterium tuberculosis and cryptococcosis). Progress in identifying predictors of specific complications as well as interventions for the prevention and treatment of these comorbidities are summarized below.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Retrovirus Life Cycles
Sexually Transmitted Infections
Pneumonia III: Complications and Assessment
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation

